Literature DB >> 33707173

Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study.

Jenny T Mao1, Bingye Xue2, Sili Fan3, Patricia Neis2, Clifford Qualls4, Larry Massie5, Oliver Fiehn3.   

Abstract

Grape seed procyanidin extract (GSE) has been shown to exert antineoplastic properties in preclinical studies. Recently, we reported findings from a modified phase I, open-label, dose escalation clinical study conducted to evaluate the safety, tolerability, MTD, and potential chemopreventive effects of leucoselect phytosome, a standardized GSE complexed with soy phospholipids to enhance bioavailability, in heavy active and former smokers. Three months of leucoselect phytosome treatment significantly decreased bronchial Ki-67 labeling index (LI), a marker of cell proliferation on the bronchial epithelium. Because GSE is widely used as a supplement to support cardiovascular health, we evaluate the impact of oral leucoselect phytosome on the fasting serum complex lipid metabolomics profiles in our participants. One month of leucoselect phytosome treatment significantly increased eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the omega-3 polyunsaturated fatty acids (n-3 PUFA) with well-established anticancer properties. Leucoselect phytosome also significantly increased unsaturated phosphatidylcholines (PC), likely from soy phospolipids in the phytosome and functioning as transporters for these PUFAs. Furthermore, 3-month leucoselect phytosome treatment significantly increased serum prostaglandin (PG) E3 (PGE3), a metabolite of EPA with anti-inflammatory and antineoplastic properties. Such increases in PGE3 correlated with reductions of bronchial Ki-67 LI (r = -0.9; P = 0.0374). Moreover, posttreatment plasma samples from trial participants significantly inhibited proliferation of human lung cancer cell lines A549 (adenocarcinoma), H520 (squamous cell carcinoma), DMS114 (small cell carcinoma), and 1198 (preneoplastic cell line). Our findings further support the potential utility of leucoselect phytosome in reducing cardiovascular and neoplastic risks in heavy former and active smokers. PREVENTION RELEVANCE: In this correlative study of leucoselect phytosome for lung cancer chemoprevention in heavy active and former smokers, we demonstrate for the first time, favorable modulations of n-3PUFA and downstream PGE3 in fasting serum, further supporting the chemopreventive potential of leucoselect phytosome against lung cancer. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707173      PMCID: PMC8225569          DOI: 10.1158/1940-6207.CAPR-20-0585

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  21 in total

1.  Oral iloprost improves endobronchial dysplasia in former smokers.

Authors:  Robert L Keith; Patrick J Blatchford; John Kittelson; John D Minna; Karen Kelly; Pierre P Massion; Wilbur A Franklin; Jenny Mao; David O Wilson; Daniel T Merrick; Fred R Hirsch; Timothy C Kennedy; Paul A Bunn; Mark W Geraci; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention.

Authors:  Jenny T Mao; Qing-Yi Lu; Bingye Xue; Patricia Neis; Felix D Zamora; Laurie Lundmark; Clifford Qualls; Larry Massie
Journal:  Cancer Prev Res (Phila)       Date:  2019-05-28

Review 3.  Prostaglandin E3 metabolism and cancer.

Authors:  Peiying Yang; Yan Jiang; Susan M Fischer
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

4.  Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting insulin-like growth factor binding protein-3, tumor cell proliferation, and angiogenic factors.

Authors:  Suhail Akhtar; Syed M Meeran; Nandan Katiyar; Santosh K Katiyar
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

5.  Grape Seed Procyanidin Extract Mediates Antineoplastic Effects against Lung Cancer via Modulations of Prostacyclin and 15-HETE Eicosanoid Pathways.

Authors:  Jenny T Mao; Jane Smoake; Heesung K Park; Qing-Yi Lu; Bingye Xue
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-22

Review 6.  Omega-3 polyunsaturated fatty acids and cancer.

Authors:  Kaipeng Jing; Tong Wu; Kyu Lim
Journal:  Anticancer Agents Med Chem       Date:  2013-10       Impact factor: 2.505

Review 7.  Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.

Authors:  Simon C Dyall
Journal:  Front Aging Neurosci       Date:  2015-04-21       Impact factor: 5.750

8.  LipidBlast in silico tandem mass spectrometry database for lipid identification.

Authors:  Tobias Kind; Kwang-Hyeon Liu; Do Yup Lee; Brian DeFelice; John K Meissen; Oliver Fiehn
Journal:  Nat Methods       Date:  2013-06-30       Impact factor: 28.547

9.  Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets.

Authors:  Dinesh Kumar Barupal; Oliver Fiehn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

10.  Grape seed procyanidin extract against lung cancer: the role of microrna-106b, bioavailability, and bioactivity.

Authors:  Bingye Xue; Qing-Yi Lu; Larry Massie; Clifford Qualls; Jenny T Mao
Journal:  Oncotarget       Date:  2018-02-16
View more
  2 in total

Review 1.  Cancer Chemoprevention: A Strategic Approach Using Phytochemicals.

Authors:  Mohan Shankar G; Mundanattu Swetha; C K Keerthana; Tennyson P Rayginia; Ruby John Anto
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 2.  The Utilization of Physiologically Active Molecular Components of Grape Seeds and Grape Marc.

Authors:  Imre Hegedüs; Kitti Andreidesz; József L Szentpéteri; Zoltán Kaleta; László Szabó; Krisztián Szigeti; Balázs Gulyás; Parasuraman Padmanabhan; Ferenc Budan; Domokos Máthé
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.